›Morphine
›0.05 to 0.1 mg/kg IV for severe pain
›Titration every 10 to 15 minutes to comfort
›Ketorolac
›15 mg IV single dose option
›Avoid in CKD and high bleeding risk
›Regional anesthesia option
›Popliteal sciatic block by trained clinician
›Neurovascular reassessment plan after block
›Open fracture bundle
›Antibiotics
›Cefazolin 2 g IV
›Repeat every 8 hours if ongoing coverage needed
›If severe cephalosporin allergy
›Clindamycin 900 mg IV
›If heavy contamination or farm injury
›Add gentamicin 5 mg/kg IV
›Add metronidazole 500 mg IV if anaerobe concern
›Tetanus prophylaxis
›Tdap booster if indicated
›Tetanus immune globulin for unknown or incomplete immunization with dirty wound
›Wound care
›Sterile saline irrigation
›Cover with sterile dressing
›Avoid aggressive ED debridement of deep tissues
Operative versus nonoperative guidance
›Treatment selection concepts
›Nonoperative candidates
›Nondisplaced extra-articular fractures
›Minimal displacement intra-articular in select cases
›High surgical risk
›Severe peripheral vascular disease
›Poor soft tissues
›Operative consideration triggers
›Displaced intra-articular fractures
›Posterior facet step-off
›Significant heel widening or varus
›Tongue-type with skin compromise
›Urgent reduction or fixation to prevent necrosis
›Open fractures
›Soft tissue timing principle
›Definitive fixation often delayed until swelling improves
›Skin wrinkling sign as readiness marker
VTE and mobility considerations
›Thrombosis risk management
›Immobilization risk discussion
›Individualized pharmacologic prophylaxis decision
›High-risk features
›Prior VTE
›Active cancer
›Prolonged immobility
›Mobility plan
›Crutch training
›Stair safety assessment